arrow
T

Timo Grimmer

TUM University Hospital
H指数:53
被引数:9,784

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microglial dynamics associate with the spatial pattern of tau deposition in early Alzheimer’s disease

小胶质细胞动力学与早期阿尔茨海默病中tau蛋白沉积的空间模式相关

2026-10-120
OA
Herpes simplex virus and kallikrein-related peptidases – a functional connection in Alzheimer‘s disease

单纯疱疹病毒和激肽释放酶相关肽酶——阿尔茨海默病中的功能联系

2026-09-240
OAAI
APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers’s disease

APOE分层的全基因组关联分析为阿尔茨海默病的遗传病因提供了见解

2026-09-140
OAAI
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies

神经元和少突胶质细胞的tau,而非星形胶质细胞的tau,与原发性tau蛋白病患者体内的tau PET信号相关。

2024-11-240
OA
Associations between sex, body mass index and the individual microglial response in Alzheimer's disease
2024-01-235
OAAI
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease

Gantenerumab在早期阿尔茨海默氏病中的两项3期试验

2023-11-1683
OA
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages
2023-08-101
OAAI
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
2023-07-2613
OAAI
Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease

Elecsys脑脊液免疫测定法可准确检测阿尔茨海默氏病,而与伴随的小血管疾病无关

2023-05-163
OAAI
GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer's Disease (AD)
2023-04-253
PRE